Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03708029 · ClinicalTrials.gov registry record · NA
Efficacy of Human Placental Graft in Diabetic Foot Ulcers
A NA study, sponsored by StimLabs.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03708029 is a NA study that was terminated before completion, run by StimLabs. The registered enrollment target is 9 participants.
The verdict
NCT03708029, a NA study, was terminated before completion, sponsored by StimLabs.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
To determine the efficacy of full-thickness placental allograft in chronic wound healing
Interventions
- OTHER Revita Allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03708029
The ClinicalTrials.gov registry entry for NCT03708029 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is StimLabs, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Revita Allograft is the first listed.
NCT03708029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03708029 about?
NCT03708029 is a clinical study titled "Efficacy of Human Placental Graft in Diabetic Foot Ulcers". To determine the efficacy of full-thickness placental allograft in chronic wound healing
What is the current status of trial NCT03708029?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-11-13. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03708029?
The interventions under investigation include: Revita Allograft (OTHER).
Who is sponsoring clinical trial NCT03708029?
This trial is sponsored by StimLabs, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.